教条 发表于 2025-3-21 17:25:09
书目名称Cannabinoids and Neuropsychiatric Disorders影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0221311<br><br> <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0221311<br><br> <br><br>著名 发表于 2025-3-22 00:15:21
http://reply.papertrans.cn/23/2214/221311/221311_2.pngSynthesize 发表于 2025-3-22 01:27:46
http://reply.papertrans.cn/23/2214/221311/221311_3.png谆谆教诲 发表于 2025-3-22 05:38:06
http://reply.papertrans.cn/23/2214/221311/221311_4.pngresilience 发表于 2025-3-22 09:57:45
http://reply.papertrans.cn/23/2214/221311/221311_5.pnglocus-ceruleus 发表于 2025-3-22 14:16:52
http://reply.papertrans.cn/23/2214/221311/221311_6.pnglocus-ceruleus 发表于 2025-3-22 17:04:50
http://reply.papertrans.cn/23/2214/221311/221311_7.pngDAFT 发表于 2025-3-22 21:33:03
https://doi.org/10.1007/978-3-662-64129-3n. There is preclinical evidence that alteration in the endocannabinoid system could potentially benefit patients suffering from depression. However, the issue of using cannabis as an anti-depressant is at an early stage of examination and there is little evidence to support it. Finally, there has bVEIL 发表于 2025-3-23 04:39:13
http://reply.papertrans.cn/23/2214/221311/221311_9.pngBarter 发表于 2025-3-23 07:24:19
Keeley C. Harmon,Joe Ann Clark,Vicki Morand seizure conditions. Clinical trials are ongoing for other forms of epilepsy and refractory seizures associated with infantile spasms, tuberous sclerosis, and Rett syndrome. Overall, adjunct CBD has been found to be generally safe and effective for treatment-resistant seizures in children with seve